สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์
Printed on 08 December 2025 22:27

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To
 Reset

BANGKOK GENOMICS INNOVATION PUBLIC COMPANY LIMITED : BKGI

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 12 record(s) found)
NameYearStatusTypePeriodAs OfDetails
Bangkok Genomics Innovation Public Company Limited2025ReviewedConsolidatedQ330/09/2025
Bangkok Genomics Innovation Public Company Limited2025ReviewedCompanyQ330/09/2025
Bangkok Genomics Innovation Public Company Limited2025ReviewedConsolidatedQ230/06/2025
Bangkok Genomics Innovation Public Company Limited2025ReviewedCompanyQ230/06/2025
Bangkok Genomics Innovation Public Company Limited2025ReviewedConsolidatedQ131/03/2025
Bangkok Genomics Innovation Public Company Limited2025ReviewedCompanyQ131/03/2025
Bangkok Genomics Innovation Public Company Limited2024AuditedConsolidatedYear31/12/2024
Bangkok Genomics Innovation Public Company Limited2024AuditedCompanyYear31/12/2024
Bangkok Genomics Innovation Public Company Limited2024ReviewedCompanyQ330/09/2024
Bangkok Genomics Innovation Public Company Limited2024ReviewedCompanyQ230/06/2024
Click here to display all results
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 8 record(s) found)
DateTimeHeadingLink
10/11/202520:44Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
13/08/202521:07Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
15/05/202517:58Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
26/02/202512:54Management Discussion and Analysis Yearly Ending 31 Dec 2024
06/11/202418:00Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
14/08/202412:36Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
15/05/202417:09Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024
19/03/202408:28Management Discussion and Analysis Yearly Ending 31 Dec 2023
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found
Last updated on 07 December 2025